 |
Tune Therapeutics
Last updated: May 05, 2024
Matt Kane, CEO
Country: USA | Funding: $40M (+)
Website: https://tunetx.com/
Tune Therapeutics develops epigenomic controls that dial gene expression up or down to potentially thwart cancers, genetic diseases and aging.
Website: https://tunetx.com/
Tune Therapeutics develops epigenomic controls that dial gene expression up or down to potentially thwart cancers, genetic diseases and aging.